Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|November 1, 2002

Supplements and Featured Publications

Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
Volume 8
Issue 17 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

over 23 years ago

Article

Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective

over 23 years ago

Article

Treatment of Rheumatoid Arthritis and Osteoarthritis Chronic Pain With Cox-2-Selective Inhibitors: A Managed Care Perspective

over 23 years ago

Article

Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs

over 23 years ago

Article

Cost-Effective Use of NSAIDs: Issues Pertinent to Coxib Use in Managed Care

over 23 years ago

Article

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC original research managerial

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

AJMC Letter to the Editor

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

AJMC original research policy

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

AJMC commentary

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

AJMC commentary

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Trending on AJMC

FAQs: FDA Lawsuit Challenges E-Cigarette Enforcement Policy, PMTA Guidance

Cognitive Rehabilitation Improves Functional Outcomes in Long COVID Brain Fog

Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MD

Active US Drug Shortages Rise for Third Straight Quarter

PMOS Linked to 4-Fold Atherosclerotic Heart Disease Risk in 2.5 Million US Women